Engels

Sample ID, analyte type, body site, and tumor status of participants with or without T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.

8 Formulieren  
  1. StudyEvent: SEV1
    1. Subject ID, race, age, gender, BMI, consent form(s) signed by participants, age of type 2 diabetes Mellitus diagnosis, age of end stage renal disease diagnosis, age of hypertension diagnosis, duration of type 2 diabetes Mellitus since diagnosis, individual has reported that he/she is on dialysis, individual has reported hypertension, individual has diabetic retinopathy reported by ophthalmologist or laser treatment with photocoagulation, HBA1C, pc1, pc2, pc3, pc4, pc5, pc6, pc7, pc8, pc9, and pc10 of participants with T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
    2. Subject ID, race, age, gender, BMI, fasting blood sugar, consent form(s) signed by participant, participant is fasting when he has not had anything to eat or drink 12 hours prior to blood draw, pc1, pc2, pc3, pc4, pc5, pc6, pc7, pc8, pc9, and pc10 of participants without T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
    3. Subject ID, family ID, mother ID, father ID, gender, and monozygotic tween ID of participants with of without T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
    4. Subject ID, consent group, subject source, source subject ID, and affection status of participants with or without T2D and involved in the "Type 2 Diabetes in African Americans, GWAS and Exome Sequencing" project.
    5. Subject ID, sample ID, sample source, source sample ID, sample use, if sample was used in analysis, and reason why sample was used in analysis of participants with or without T2D and involved in the "Type 2 Diabetes in African Americans, GWAS and Exome Sequencing" project.
    6. Subject ID, gender, age, T2D, diabetes age of diagnosis at time of study, height, weight, BMI, consortium name, and cohort name of participants with or without T2D and involved in the "Type 2 Diabetes Genetic Exploration by Next-generation Sequencing in Multi-Ethnic Samples (T2D-GENES) Project 1: Wake Forest African American Type 2 Diabetes" project.
    7. Sample ID, body site where sample was obtained, analyte type, histological type of sample, sequencing center, and tumor status of participants with or without T2D and involved in the "Type 2 Diabetes Genetic Exploration by Next-generation Sequencing in Multi-Ethnic Samples (T2D-GENES) Project 1: Wake Forest African American Type 2 Diabetes" project.
    8. Sample ID, analyte type, body site, and tumor status of participants with or without T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
pht005640
Beschrijving

pht005640

Alias
UMLS CUI [1,1]
C3846158
De-identified sample ID
Beschrijving

SAMPID

Datatype

string

Alias
UMLS CUI [1,1]
C4684638
UMLS CUI [1,2]
C1299222
Body site where sample was collected
Beschrijving

BODY_SITE

Datatype

string

Alias
UMLS CUI [1,1]
C0449705
Analyte type
Beschrijving

ANALYTE_TYPE

Datatype

string

Alias
UMLS CUI [1,1]
C4744818
Tumor status
Beschrijving

IS_TUMOR

Datatype

text

Alias
UMLS CUI [1,1]
C0475752
Terug naar het begin van de pagina

Similar models

Sample ID, analyte type, body site, and tumor status of participants with or without T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.

8 Formulieren
  1. StudyEvent: SEV1
    1. Subject ID, race, age, gender, BMI, consent form(s) signed by participants, age of type 2 diabetes Mellitus diagnosis, age of end stage renal disease diagnosis, age of hypertension diagnosis, duration of type 2 diabetes Mellitus since diagnosis, individual has reported that he/she is on dialysis, individual has reported hypertension, individual has diabetic retinopathy reported by ophthalmologist or laser treatment with photocoagulation, HBA1C, pc1, pc2, pc3, pc4, pc5, pc6, pc7, pc8, pc9, and pc10 of participants with T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
    2. Subject ID, race, age, gender, BMI, fasting blood sugar, consent form(s) signed by participant, participant is fasting when he has not had anything to eat or drink 12 hours prior to blood draw, pc1, pc2, pc3, pc4, pc5, pc6, pc7, pc8, pc9, and pc10 of participants without T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
    3. Subject ID, family ID, mother ID, father ID, gender, and monozygotic tween ID of participants with of without T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
    4. Subject ID, consent group, subject source, source subject ID, and affection status of participants with or without T2D and involved in the "Type 2 Diabetes in African Americans, GWAS and Exome Sequencing" project.
    5. Subject ID, sample ID, sample source, source sample ID, sample use, if sample was used in analysis, and reason why sample was used in analysis of participants with or without T2D and involved in the "Type 2 Diabetes in African Americans, GWAS and Exome Sequencing" project.
    6. Subject ID, gender, age, T2D, diabetes age of diagnosis at time of study, height, weight, BMI, consortium name, and cohort name of participants with or without T2D and involved in the "Type 2 Diabetes Genetic Exploration by Next-generation Sequencing in Multi-Ethnic Samples (T2D-GENES) Project 1: Wake Forest African American Type 2 Diabetes" project.
    7. Sample ID, body site where sample was obtained, analyte type, histological type of sample, sequencing center, and tumor status of participants with or without T2D and involved in the "Type 2 Diabetes Genetic Exploration by Next-generation Sequencing in Multi-Ethnic Samples (T2D-GENES) Project 1: Wake Forest African American Type 2 Diabetes" project.
    8. Sample ID, analyte type, body site, and tumor status of participants with or without T2D and involved in the "A Whole Genome Association Search for Type 2 Diabetes Genes in African Americans" project.
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
pht005640
C3846158 (UMLS CUI [1,1])
SAMPID
Item
De-identified sample ID
string
C4684638 (UMLS CUI [1,1])
C1299222 (UMLS CUI [1,2])
BODY_SITE
Item
Body site where sample was collected
string
C0449705 (UMLS CUI [1,1])
ANALYTE_TYPE
Item
Analyte type
string
C4744818 (UMLS CUI [1,1])
Item
Tumor status
text
C0475752 (UMLS CUI [1,1])
IS_TUMOR
Code List
Tumor status
CL Item
Is not a tumor (N)
C0027651 (UMLS CUI [1,1])
C1518422 (UMLS CUI [1,2])
CL Item
Is tumor (Y)
C0027651 (UMLS CUI [1,1])
Terug naar het begin van de pagina